Human TRF4 2 (PAPD5) activation kit by CRISPRa
CAT#: GA112029
TENT4B CRISPRa kit - CRISPR gene activation of human terminal nucleotidyltransferase 4B
CNY 12,255.00
Specifications
Product Data | |
Format | 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug) |
Symbol | TENT4B |
Locus ID | 64282 |
Kit Components | GA112029G1, TRF4 2 gRNA vector 1 in pCas-Guide-GFP-CRISPRa GA112029G2, TRF4 2 gRNA vector 2 in pCas-Guide-GFP-CRISPRa GA112029G3, TRF4 2 gRNA vector 3 in pCas-Guide-GFP-CRISPRa 1 CRISPRa-Enhancer vector, SKU GE100056 1 CRISPRa scramble vector, SKU GE100077 |
Disclaimer | These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc. |
Reference Data | |
RefSeq | NM_001040284, NM_001040285, NM_022447, NM_001365323, NM_001365324 |
Synonyms | TRF4-2 |
Summary | Terminal nucleotidyltransferase that catalyzes preferentially the transfert of ATP and GTP on RNA 3' poly(A) tail creating a heterogeneous 3' poly(A) tail leading to mRNAs stabilization by protecting mRNAs from active deadenylation (PubMed:21788334, PubMed:30026317). Also functions as a catalytic subunit of a TRAMP-like complex which has a poly(A) RNA polymerase activity and is involved in a post-transcriptional quality control mechanism. Polyadenylation with short oligo(A) tails is required for the degradative activity of the exosome on several of its nuclear RNA substrates. Doesn't need a cofactor for polyadenylation activity (in vitro) (PubMed:21788334, PubMed:21855801). Required for cytoplasmic polyadenylation of mRNAs involved in carbohydrate metabolism, including the glucose transporter SLC2A1/GLUT1 (PubMed:28383716). Plays a role in replication-dependent histone mRNA degradation, probably through terminal uridylation of mature histone mRNAs. May play a role in sister chromatid cohesion (PubMed:18172165). Mediates 3' adenylation of the microRNA MIR21 followed by its 3'-to-5' trimming by the exoribonuclease PARN leading to degradation (PubMed:25049417). Mediates 3' adenylation of H/ACA box snoRNAs (small nucleolar RNAs) followed by its 3'-to-5' trimming by the exoribonuclease PARN which enhances snoRNA stability and maturation (PubMed:22442037).[UniProtKB/Swiss-Prot Function] |
Documents
Resources
基因表达相关资源 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
KN214986 | PAPD5 - human gene knockout kit via CRISPR, HDR mediated |
CNY 12,260.00 |
|
KN214986BN | PAPD5 - human gene knockout kit via CRISPR, HDR mediated |
CNY 12,260.00 |
|
KN214986LP | PAPD5 - human gene knockout kit via CRISPR, HDR mediated |
CNY 12,260.00 |
|
KN214986RB | PAPD5 - human gene knockout kit via CRISPR, HDR mediated |
CNY 12,260.00 |
|
KN414986 | PAPD5 - KN2.0, Human gene knockout kit via CRISPR, non-homology mediated. |
CNY 8,680.00 |